陕西医学杂志
陝西醫學雜誌
협서의학잡지
SHAANXI MEDICAL JOURNAL
2013年
10期
1400-1401
,共2页
孙为%王翔%田竹芳%王芳
孫為%王翔%田竹芳%王芳
손위%왕상%전죽방%왕방
糖尿病神经病变/药物疗法%硫辛酸/治疗应用%@血栓通
糖尿病神經病變/藥物療法%硫辛痠/治療應用%@血栓通
당뇨병신경병변/약물요법%류신산/치료응용%@혈전통
Diabetic neuropathies/drug therapy%Thioctic acid/therapeutic use%@Xueshuantong
目的:观察硫辛酸联合血栓通治疗糖尿病周围神经病变的疗效。方法:72例糖尿病周围神经病变患者,随机分为治疗组37例,给予硫辛酸联合血栓通治疗;对照组35例,仅给予硫辛酸治疗,连续治疗2周。观察2组患者神经症状和神经传导速度的变化。结果:治疗组糖尿病周围神经病变有效率明显高于对照组(97.29%,68.57%)( P<0.05)。治疗组治疗后正中神经和腓总神经的传导速度均较治疗前有所改善(P<0.05),且治疗组治疗后神经传导速度好转明显高于对照组(P<0.05)。结论:硫辛酸联合血栓通能够有效的治疗糖尿病周围神经病变。
目的:觀察硫辛痠聯閤血栓通治療糖尿病週圍神經病變的療效。方法:72例糖尿病週圍神經病變患者,隨機分為治療組37例,給予硫辛痠聯閤血栓通治療;對照組35例,僅給予硫辛痠治療,連續治療2週。觀察2組患者神經癥狀和神經傳導速度的變化。結果:治療組糖尿病週圍神經病變有效率明顯高于對照組(97.29%,68.57%)( P<0.05)。治療組治療後正中神經和腓總神經的傳導速度均較治療前有所改善(P<0.05),且治療組治療後神經傳導速度好轉明顯高于對照組(P<0.05)。結論:硫辛痠聯閤血栓通能夠有效的治療糖尿病週圍神經病變。
목적:관찰류신산연합혈전통치료당뇨병주위신경병변적료효。방법:72례당뇨병주위신경병변환자,수궤분위치료조37례,급여류신산연합혈전통치료;대조조35례,부급여류신산치료,련속치료2주。관찰2조환자신경증상화신경전도속도적변화。결과:치료조당뇨병주위신경병변유효솔명현고우대조조(97.29%,68.57%)( P<0.05)。치료조치료후정중신경화비총신경적전도속도균교치료전유소개선(P<0.05),차치료조치료후신경전도속도호전명현고우대조조(P<0.05)。결론:류신산연합혈전통능구유효적치료당뇨병주위신경병변。
Objective :To investigate the effects for lipoic acid Combined with Xueshuantong in the treat-ment of diabetic peripheral neuropathy .Methods :Seventy-two patients for diabetic in Center Hospital of Xi′an were randomly divided into 2 groups:Treatment group(n=37) injected Lipoic acid Combined Xueshuantong everyday and Control group(n= 35) only given Lipoic acid everyday .Then observe the changes of neurological symptoms and nerve conduction velocity on EMG in two groups .Results :The effective power of diabetic peripheral neuropathy in treatment group was higher remarkably than that in control group ,efficiency was statistically significant ( P< 0 . 05) .After treatment ,the median nerve and peroneal nerve conduction velocity were improved markedly (P<0 .05) , and nerve conduction velocity was significantly higher than that in the control group statistically significant (P<0 . 05) .Conclusion:Lipoic acid combined with Xueshuantong can effectively treat diabetic peripheral neuropathy .